Joanna M. Gotfrit

Ottawa, ON K1H8L6, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Eastern Canadian Gastrointestinal Cancer Consensus Conference 2024.

Eastern Canadian Gastrointestinal Cancer Consensus Conference 2024.

Journal: Current oncology (Toronto, Ont.)

Published: February 15, 2025

Administration of FOLFIRINOX for Advanced Pancreatic Cancer: Physician Practice Patterns During Early Use.

Administration of FOLFIRINOX for Advanced Pancreatic Cancer: Physician Practice Patterns During Early Use.

Journal: Current oncology (Toronto, Ont.)

Published: December 09, 2024

Implementation of a Hepatitis B Screening Program in Patients Receiving Systemic Anti-Cancer Therapy.

Implementation of a Hepatitis B Screening Program in Patients Receiving Systemic Anti-Cancer Therapy.

Journal: Current oncology (Toronto, Ont.)

Published: November 08, 2024

New Anticancer Drugs: Reliably Assessing "Value" While Addressing High Prices.

New Anticancer Drugs: Reliably Assessing "Value" While Addressing High Prices.

Journal: Current oncology (Toronto, Ont.)

Published: February 27, 2024

Access to Oncology Medicines in Canada: Consensus Forum for Recommendations for Improvement.

Access to Oncology Medicines in Canada: Consensus Forum for Recommendations for Improvement.

Journal: Current oncology (Toronto, Ont.)

Published: February 12, 2024

Impact of Systemic Delays for Patient Access to Oncology Drugs on Clinical, Economic, and Quality of Life Outcomes in Canada: A Call to Action.

Impact of Systemic Delays for Patient Access to Oncology Drugs on Clinical, Economic, and Quality of Life Outcomes in Canada: A Call to Action.

Journal: Current oncology (Toronto, Ont.)

Published: December 05, 2023

The Pathway for New Cancer Drug Access in Canada.

The Pathway for New Cancer Drug Access in Canada.

Journal: Current oncology (Toronto, Ont.)

Published: December 21, 2021

Determinants of the Cancer Drug Funding Process in Canada.

Determinants of the Cancer Drug Funding Process in Canada.

Journal: Current oncology (Toronto, Ont.)

Published: December 20, 2021

The Impact of Chronic Kidney Disease in Patients With Locally Advanced Rectal Cancer Treated With Neoadjuvant Chemoradiation.

The Impact of Chronic Kidney Disease in Patients With Locally Advanced Rectal Cancer Treated With Neoadjuvant Chemoradiation.

Journal: Diseases of the colon and rectum

Published: October 17, 2021

Eastern Canadian Gastrointestinal Cancer Consensus Conference 2019.

Eastern Canadian Gastrointestinal Cancer Consensus Conference 2019.

Journal: Current oncology (Toronto, Ont.)

Published: April 30, 2021

Phosphorylated transducer and activator of transcription-3 (pSTAT3) immunohistochemical expression in paired primary and metastatic colorectal cancer.

Phosphorylated transducer and activator of transcription-3 (pSTAT3) immunohistochemical expression in paired primary and metastatic colorectal cancer.

Journal: Translational oncology

Published: November 11, 2020

The impact of driving time, distance, and socioeconomic factors on outcomes of patients with locally advanced rectal cancer.

The impact of driving time, distance, and socioeconomic factors on outcomes of patients with locally advanced rectal cancer.

Journal: Public health in practice (Oxford, England)

Published: April 21, 2020

Showing 1-12 of 18

Last Updated: 09/26/2026